Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.
Quinti L, Chopra V, Rotili D, Valente S, Amore A, Franci G, Meade S, Valenza M, Altucci L, Maxwell MM, Cattaneo E, Hersch S, Mai A, Kazantsev A. Quinti L, et al. Among authors: hersch s. PLoS Curr. 2010 Sep 2;2:RRN1172. doi: 10.1371/currents.RRN1172. PLoS Curr. 2010. PMID: 20877454 Free PMC article.
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models.
Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, Cipicchio PM, Lauver MA, Choi SH, Silverman RB, Ferrante RJ, Hersch S, Kazantsev AG. Chopra V, et al. Among authors: hersch s. Cell Rep. 2012 Dec 27;2(6):1492-7. doi: 10.1016/j.celrep.2012.11.001. Epub 2012 Nov 29. Cell Rep. 2012. PMID: 23200855 Free PMC article.
Mechanisms of copper ion mediated Huntington's disease progression.
Fox JH, Kama JA, Lieberman G, Chopra R, Dorsey K, Chopra V, Volitakis I, Cherny RA, Bush AI, Hersch S. Fox JH, et al. Among authors: hersch s. PLoS One. 2007 Mar 28;2(3):e334. doi: 10.1371/journal.pone.0000334. PLoS One. 2007. PMID: 17396163 Free PMC article.
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease.
Fox JH, Connor T, Chopra V, Dorsey K, Kama JA, Bleckmann D, Betschart C, Hoyer D, Frentzel S, Difiglia M, Paganetti P, Hersch SM. Fox JH, et al. Among authors: hersch sm. Mol Neurodegener. 2010 Jun 22;5:26. doi: 10.1186/1750-1326-5-26. Mol Neurodegener. 2010. PMID: 20569486 Free PMC article.
176 results